• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

An RNA aptamer containing two binding sites against the HCV minus-IRES domain I.

作者信息

Konno Keisuke, Iizuka Mana, Fujita Syusuke, Nishikawa Satoshi, Hasegawa Tsunemi, Fukuda Kotaro

机构信息

Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, Yamagata, Japan.

出版信息

Nucleosides Nucleotides Nucleic Acids. 2011 Mar;30(3):185-202. doi: 10.1080/15257770.2011.562475.

DOI:10.1080/15257770.2011.562475
PMID:21491328
Abstract

The higher order structure of HCV (-)IRES containing five stem-loop structures (domain I) is essential for HCV replication because the viral RNA-dependent RNA polymerase, NS5B, recognizes it as the initiation site for plus-strand synthesis. To inhibit a de novo synthesis of plus-strand RNA molecules, in vitro selection against (-)IRES domain I was performed. One of the obtained aptamers, AP30, contained two consensus sequences within a random sequence region. Two consensus sequences form two apical loops and mutational analysis showed that both sequences were essential for binding to the target and for inhibiting NS5B-mediated RNA synthesis in vitro.

摘要

相似文献

1
An RNA aptamer containing two binding sites against the HCV minus-IRES domain I.
Nucleosides Nucleotides Nucleic Acids. 2011 Mar;30(3):185-202. doi: 10.1080/15257770.2011.562475.
2
Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.丙型肝炎病毒负链内部核糖体进入位点结构域I特异性RNA适配体的分离与鉴定
Nucleic Acids Symp Ser (Oxf). 2008(52):493-4. doi: 10.1093/nass/nrn250.
3
Isolation of RNA aptamers specific for the HCV minus-IRES domain I.丙型肝炎病毒负链内部核糖体进入位点结构域I特异性RNA适配体的分离
Nucleic Acids Symp Ser (Oxf). 2007(51):393-4. doi: 10.1093/nass/nrm197.
4
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.针对 HCV NS5B RNA 复制酶的 HCV 特异性 RNA 适体抑制 HCV 复制。
J Virol. 2013 Jun;87(12):7064-74. doi: 10.1128/JVI.00405-13. Epub 2013 Apr 17.
5
RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.通过靶向 CRE-5BSL3.2 结构域,RNA 适体介导的 HCV 复制干扰。
J Viral Hepat. 2013 Feb;20(2):103-12. doi: 10.1111/j.1365-2893.2012.01629.x. Epub 2012 Jul 17.
6
Selection of 3'-template bases and initiating nucleotides by hepatitis C virus NS5B RNA-dependent RNA polymerase.丙型肝炎病毒NS5B RNA依赖性RNA聚合酶对3'-模板碱基和起始核苷酸的选择
J Virol. 2002 Jul;76(14):7030-9. doi: 10.1128/jvi.76.14.7030-7039.2002.
7
Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.蛋白激酶 C 相关激酶 2 对丙型肝炎病毒 RNA 聚合酶 ser29 和 ser42 的磷酸化调节病毒 RNA 复制。
J Virol. 2014 Oct;88(19):11240-52. doi: 10.1128/JVI.01826-14. Epub 2014 Jul 16.
8
Template requirements for de novo RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase on the viral X RNA.丙型肝炎病毒非结构蛋白5B聚合酶在病毒X RNA上进行从头RNA合成的模板要求。
J Virol. 2002 Jul;76(14):6944-56. doi: 10.1128/jvi.76.14.6944-6956.2002.
9
Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template.丙型肝炎病毒聚合酶在最小病毒RNA模板上的模板要求及起始位点选择
J Biol Chem. 2000 Jun 9;275(23):17710-7. doi: 10.1074/jbc.M908781199.
10
HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA.
Eur J Biochem. 2001 Nov;268(22):5857-67. doi: 10.1046/j.0014-2956.2001.02532.x.

引用本文的文献

1
Aptamers for Viral Detection and Inhibition.适体在病毒检测和抑制中的应用。
ACS Infect Dis. 2022 Apr 8;8(4):667-692. doi: 10.1021/acsinfecdis.1c00546. Epub 2022 Feb 27.
2
Aptamers for Anti-Viral Therapeutics and Diagnostics.适体在抗病毒治疗和诊断中的应用
Int J Mol Sci. 2021 Apr 17;22(8):4168. doi: 10.3390/ijms22084168.
3
Oligonucleotide aptamers: potential novel molecules against viral hepatitis.寡核苷酸适配体:对抗病毒性肝炎的潜在新型分子。
Res Pharm Sci. 2017 Apr;12(2):88-98. doi: 10.4103/1735-5362.202447.
4
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.适体作为人类病毒诊断工具和抗病毒剂的应用。
Pharmaceuticals (Basel). 2016 Dec 16;9(4):78. doi: 10.3390/ph9040078.
5
Aptamers in diagnostics and treatment of viral infections.适体在病毒感染诊断与治疗中的应用
Viruses. 2015 Feb 16;7(2):751-80. doi: 10.3390/v7020751.
6
Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site.丙型肝炎病毒翻译抑制剂靶向内部核糖体进入位点。
J Med Chem. 2014 Mar 13;57(5):1694-707. doi: 10.1021/jm401312n. Epub 2013 Nov 5.